Tumour Reactions to Hypoxia

被引:38
|
作者
Voss, M. J. [1 ]
Niggemann, B. [1 ]
Zaenker, K. S. [1 ]
Entschladen, F. [1 ]
机构
[1] Univ Witten Herdecke, Inst Immunol, D-58448 Witten, Germany
关键词
Hypoxia; angiogenesis; lymphangiogenesis; neoneurogenesis; metabolic shift; cell migration; metastasis formation; ENDOTHELIAL GROWTH-FACTOR; LYMPH-NODE METASTASIS; INDUCIBLE FACTOR-I; PERINEURAL INVASION; GENE-EXPRESSION; PROGNOSTIC-SIGNIFICANCE; NEUROTROPHIC FACTORS; INDUCED MIGRATION; CANCER CELLS; FACTOR VEGF;
D O I
10.2174/156652410791317020
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Fast growing solid tumours generally lack an inner organisation, which causes the problem of a sufficient nutrient of each part of the tumour that then happens only by diffusion. The low oxygen supply leads to the activation of hypoxia-inducible factors, which regulate a plethora of genes. The reaction of tumour cells to hypoxia can be divided into two parts: On the one hand, there are signal substances, predominantly growth factors and cytokines, which provoke the vascularisation (angiogenesis), lymph vessel development (lymphangiogenesis), and the innervation (neoneurogenesis) of tumours and thus connect the tumour to structures of the environment. On the other hand, genes for intracellular proteins and receptors are regulated, which lead to changes of the tumour cell functions. Best characterised is the metabolic shift, a high anaerobic glycolytic activity and simultaneously a reduction of respiration. Furthermore, proliferation, dedifferentiation, resistance to apoptosis, and the metastatic potential are affected. With regard to the latter, we herein show that the migratory activity and velocity of PC-3 human prostate carcinoma cells significantly increase under oxygen-deprivation, which might be an explanation for the increasing number of experimental and clinical hints, that an anti-angiogenic therapy can promote the metastasis formation.
引用
收藏
页码:381 / 386
页数:6
相关论文
共 50 条
  • [1] Tumour hypoxia
    Horsman, M.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S112 - S112
  • [2] Tumour Hypoxia
    West, C. M.
    Slevin, F.
    CLINICAL ONCOLOGY, 2019, 31 (09) : 595 - 599
  • [3] Radiotherapy and tumour hypoxia
    Albert Biete Solá
    Angels Rovirosa Casino
    Revista de Oncología, 2002, 4 (4): : 217 - 220
  • [4] Identifying tumour hypoxia
    Nordsmark, M
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 989 - 989
  • [5] Tumour hypoxia in driving genomic instability and tumour evolution
    Alexandru Suvac
    Jack Ashton
    Robert G. Bristow
    Nature Reviews Cancer, 2025, 25 (3) : 167 - 188
  • [6] Tumour hypoxia and treatment outcome
    Lartigau, E
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 990 - 990
  • [7] Modulation of tumour vasculature: effects on hypoxia and tumour regrowth
    Muschel, J. H.
    Im, J. H.
    Fokas, E.
    Kelly, C. J.
    Gordon-Weeks, A.
    Lim, S. Y.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S261 - S261
  • [8] Hypoxia, autophagy and tumour metabolism
    Pouysseaur, J.
    Chiche, J.
    Garcia-Medina, R.
    Bellot, G.
    Dayan, F.
    Roux, D.
    Mazure, N.
    EJC SUPPLEMENTS, 2008, 6 (09): : 65 - 65
  • [9] Hypoxia and energetic tumour metabolism
    Brahimi-Horn, M. Christiane
    Bellot, Gregory
    Pouyssegur, Jacques
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2011, 21 (01) : 67 - 72
  • [10] Tumour hypoxia and vascularity in lymphoma
    Sibtain, A
    Wilson, GD
    Hoskin, PJ
    BRITISH JOURNAL OF CANCER, 2001, 85 : 36 - 36